论文部分内容阅读
目的研究参一胶囊联合生血宝合剂对肿瘤患者放化疗后毒副反应及免疫功能低下的影响价值。方法对2015年6月-2016年6月我院收治的90例采用放化疗治疗的肿瘤患者进行观察,所有患者放化疗结束后立即采用生血宝合剂、参一胶囊剂联合治疗2周,观察患者免疫功能及毒副反应发生情况。结果治疗后患者的血液各项指标水平明显优于治疗前;数据对比差异有统计学意义(P<0.05)。放化疗引起的毒副反应有22例,发生率为24.44%。结论对肿瘤患者放化疗后立即采用参一胶囊、生血宝合剂联合治疗可以提高患者的免疫功能,降低放化疗引起的毒副反应发生率,具有较高的临床应用价值。
Objective To study the effect of Shenyi Capsule combined with Shengxuebao Mixture on the toxic and side effects of radiotherapy and chemotherapy and immune dysfunction in cancer patients. Methods 90 patients admitted to our hospital from June 2015 to June 2016 with radiotherapy and chemotherapy were observed. All patients were treated with Sheng Xue Bao Mixture and Shen Capsules for 2 weeks immediately after the end of radiotherapy and chemotherapy. Patients were observed Immune function and side effects. Results After treatment, the blood levels of all the patients were significantly better than those before treatment; the difference was statistically significant (P <0.05). Radiotherapy and chemotherapy induced toxicity in 22 cases, the incidence was 24.44%. Conclusions The combination of Shenyi Capsule and Shengxuebao Mixture can increase the immune function of patients and reduce the incidence of toxic and side effects caused by radiotherapy and chemotherapy, which has a high clinical value.